Healthcare | August 16, 2021
Apollo Hospitals PAT at Rs 489.28 cr. in Q1FY22
The hospital chain aggressively embarks on digitisation and is e-health ready
The hospital chain aggressively embarks on digitisation and is e-health ready
The MoU was signed on World Organ Donation Day which falls on August 13
This therapy may provide the first potential oral treatment for COVID-19, recognizing the global emergency of new SARS-CoV-2 variants
Studies include Alpha, Beta, Gamma, Delta, Epsilon and Iota and it maintains antibodies for six months after the second dose
Idiopathic hypersomnia is a life-long condition, and the approval of Xywav will be instrumental in providing treatment for symptoms such as excessive sleepiness and difficulty waking, and in effectively managing this debilitating disorder
The transaction improves patient experience, patient outcomes and aims to reduce health care costs
Substantial reduction in losses
A treatment to prevent extreme symptoms and cut hospitalisation
SAB-185 is currently being evaluated in NIH-sponsored Phase 2/3 adaptive trial
The company is eligible for 12 months exclusivity from launch
Subscribe To Our Newsletter & Stay Updated
